A cancer pharmaceutical that is often used off-label as a treatment for diabetes is under investigation after it caused 12 diabetic patients who took it to go blind .
Health authorities in Punjab, Pakistan, where the incident took place say that Avastin, a cancer drug injection made by Swiss pharmaceutical giant Roche, say they are currently probing two distributors of the shot, which contains the active ingredient bevacizumab.
In Pakistan, bevacizumab is licensed for use in the same ways it was first approved for use in the United States back in 2004, particularly in the treatment of colon cancer. Since then, bevacizumab has been given the green light for use in treating cancers of the lung, kidneys, and brain.The Drug Regulatory Authority of Pakistan (DRAP) recently gave bevacizumab the go-ahead to also be used in treating colorectal cancer and other forms of metastatic carcinomas.(Related: Back in 2008, the U.S. […]
Read the Whole Article From the Source: www.naturalnews.com